ArticlePharmacoEconomics - open2020

Cost-Effectiveness Analysis of Nintedanib Versus Pirfenidone in Idiopathic Pulmonary Fibrosis in Belgium.

C Rinciog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.